As we bid farewell to another transformative year, pride and gratitude swell among us. We encourage everyone to take a moment to reflect on all the remarkable strides made in patient care, from the lab to the operating room, in 2023.
A groundbreaking Phase II clinical trial for a mRNA neoantigen vaccine for pancreatic cancer is underway. With a mortality rate of nearly 90 percent, this could be a transformative development in the treatment of pancreatic cancer. Dr. John Chabot shares what you need to know.
Interview with Vincent Duron, MD about his work, career, and fetal surgery including minimally invasive prenatal repair of spina bifida and treatment of CDH.
The first robotic kidney transplant at Columbia is a groundbreaking fete, but what it really demonstrates is the power of love and beautiful bond of family.
The Department of Surgery is pleased to announce the appointment of Dr. Katherine Fischkoff as the new Chief of the Division of General Surgery at NewYork-Presbyterian/Columbia University Irving Medical Center. As a distinguished general and acute care surgeon with a keen interest in medical ethics, Dr. Fischkoff brings a wealth of expertise to her leadership role.
